Emerging Concepts and Targets in Islet Biology Organizer(s): Rohit N. Kulkarni, Raghavendra G. Mirmira and Eckhard Lammert Date: April 06 - 11, 2014 Location: Keystone Resort, Keystone, CO, USAThis meeting focuses on signaling pathways that impact islet cell physiology via their ability to enhance the function, promote survival and/or increase proliferation of islet cells. This is a crucial area of islet biology that has not been the focus of recent scientific meetings and is therefore timely with respect to new therapeutic approaches to combat diabetes. The meeting includes a discussion of potential drug targets involving islet cells, both localized to the islet milieu and from different organ systems, as well as of genes newly discovered to be involved in islet dysfunction. In addition, since efforts aimed at assessing the efficacy of drug targeting require means to quantitatively assess islet responses in vivo, the meeting includes a session focused on non-invasive assessment of beta cell mass and function. Finally, workshops cover areas of major interest to the scientific community (academia and industry): drug targets currently in clinical trials; stem cell and iPS research investments; and the procurement and distribution of high-quality human islets and pancreas samples for research work. Scholarship Deadline: December 9 2013 Discounted Abstract Deadline: December 9 2013 Abstract Deadline: January 14 2014 Discounted Registration Deadline: February 5 2014 We gratefully acknowledge additional support for this conference from:  We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Novartis Institutes for BioMedical Research
We gratefully acknowledge the generous grant for this conference provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Grant No. 5R13DK084688-05 The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |